XYMOGEN Launches Pharmaceutix(TM) Medical Foods Division and Partners With Acasti Pharma to Bring Revolutionary Medical Food to United States and Beyond  
7/11/2012 9:28:09 AM

ORLANDO, Fla., July 11, 2012 (GLOBE NEWSWIRE) -- XYMOGEN announced today an exclusive partnership with Acasti Pharma, the biopharmaceutical company with whom they will launch the worldwide distribution of LipiChol540™, a physician-prescribed medical food to manage omega-3 phospholipid deficiency. The formula will be distributed by Pharmaceutix Medical Foods, a wholly owned subsidiary of XYMOGEN.